The weight-loss pharmaceutical market is evolving rapidly, with emerging drugs looking to act on several mechanisms concurrently
About 5% find it intolerable and stop
Understanding Common GLP-1 Side Effects: A Patient's Perspective When Lili Zarghami walked out of her doctors office with a free box of Mounjaro a glucagon-like peptide-1 (GLP-1) agonist from Eli Lilly she felt hopeful that the drug might help her shed extra pounds she had gained related to having polycystic ovary syndrome (PCOS)
The FDA pathway is on track NDA by Q4 2026, approval by late 2027, launch in early 2028
A common change that has a lot of people worried is how plans are handling GLP-1 medications diabetes and weight loss drugs you may know better by their common brand names, like Ozempic, Wegovy, Mounjaro, and Zepbound
A growing body of research suggests GLP-1s can help reverse fertility issues caused by obesity, including in women with PCOS/PMOS